Form 4: Natera Executive Sells Shares to Cover Tax Obligations

Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc., sold 707 shares of common stock to cover tax obligations related to vesting RSUs.

Summary

• On March 28, 2024, Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc., sold 707 shares of Natera's common stock.
• The shares were sold at a price of $90.4158 per share.
• The sale was executed to satisfy tax withholding and remittance obligations related to the vesting of Restricted Stock Units (RSUs).
• The transaction was made pursuant to a pre-arranged written instruction intended to comply with Rule 10b5-1(c) under the Exchange Act.
• Following the transaction, Moshkevich directly owns 197,560 shares of Natera's common stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating a routine transaction. It doesn't convey any particularly positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of the financial markets, providing transparency into the transactions of company insiders. This particular filing indicates a sale of shares to cover tax obligations, which is a common practice.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale (tax obligations) and the relatively small number of shares involved.

Key Dates